A Good Cancer research Bio company? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : A Good Cancer research Bio company?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: B. Ino who wrote (20)	9/14/1996 10:59:00 AM
From: Henry Niman	of 76

Bryan, Yesterday, IBD's Medical-Biomed/Genetics group rose a solid 1.5%. That gain coupled with Thursday's 0.8% gain brought the sector's year to date loss down to -0.2%. On Jan 1 the sector had just begun a major move sparked by CNTO's Reopro results. CNBC has been calling for a major move due to the many conferences scheduled during the upcoming months as well as Gold money moving into Biotechs, good 3Q earnings, and "smart money" moves. Thursday, LGND wowed the Bear Stearns attendees and rose 2 1/2 on record volume (1.5 million shares). Although the price dropped 3/4 yesterday on just under 400,000 shares, some of the price drop may have been caused by MMs positioning the price for some major activity next week. Interestingly,LGND's accumulation/distribution ROSE yesterday (from "C" to "B") suggesting that much of yesterday's activity was due to BUYING even though the price dropped. Henry

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next